Fgf14<sup>-/-</sup> mice showed increased expression of cannabinoid receptor without alterations of dopaminergic system in mPFC, suggesting a link between Fgf14 and endocannabinoid system in the control mechanisms underlying depression. Here, FGF14 is linked to depressive symptom measurement.